StonvexLoading…
StonvexStonvexStonvexCore line items from INNV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $727.76M | $475.81M | $236.10M | $853.70M |
Operating Income | $-7.53M | $21.55M | $8.29M | $-29.76M |
Net Income | $-10.82M | $18.64M | $8.02M | $-30.31M |
EPS (Diluted) | $-0.08 | $0.14 | $0.06 | $-0.22 |
Total Assets | $547.39M | $527.48M | $510.23M | $526.85M |
Total Liabilities | $288.50M | $238.72M | $234.47M | $263.94M |
Cash & Equivalents | $95.54M | $83.20M | $67.15M | $64.13M |
Free Cash Flow OCF − CapEx | $33.38M | $18.84M | $-153.00K | $26.60M |
Shares Outstanding | 135.71M | 135.70M | 135.68M | 135.44M |